Stemnion, Inc.

Noveome Biotherapeutics, Inc.

Linda O Palladino

Vivienne S Marshall

Catherine J Trumpower

George L Sing

Charlotte A Smith

David L Steed

Larry Richard Brown

Charlotte A Emig

Diana L Clarke

Martin C Robson

The invention is directed to methods for treating urushiol-induced contact dermatitis. Specifically, the invention is directed to treating and reducing inflammation associated with poison ivy, poison sumac and poison oak by administering to a subject suffering from such conditions novel cellular factor-containing solution compositions (referred to herein as 'CFS' compositions), including novel sustained-release cellular factor-containing solution compositions (referred to herein as 'SR-CFS' compositions).

Methods for treating urushiol-induced contact dermatitis

The invention is directed to novel cellular factor-containing solution compositions (referred to herein as 'CFS' compositions), including novel sustained-release cellular factor-containing solution compositions (referred to herein as 'SR-CFS' compositions), methods of making such novel compositions and uses thereof.

Cellular-factor containing solution compositions

The invention is directed to methods for treating pustular conditions of the skin, for example, acne. Such methods utilize novel compositions, including but not limited to extraembryonic cytokine secreting cells (herein referred to as ECS cells), including, but not limited to, amnion-derived multipotent progenitor cells (herein referred to as AMP cells), conditioned media derived therefrom (herein referred to as amnion-derived cellular cytokine solution or ACCS), cell lysates derived therefrom, and cell products derived therefrom, each alone or in combination.

Methods for treating pustular psoriasis

The invention is directed to a wound healing device. Such wound healing device utilizes novel wound healing compositions embedded onto or into a natural plant-derived cloth-based matrix.

Wound healing device comprising a cloth embedded with a wound healing composition

Wound healing device

Kits for treating wounds

The invention is directed to methods related to surgery, for example gastrointestinal surgery. In particular, the invention is methods of treating fistulae, promoting accelerated healing of anastomoses and preventing failure of anastomoses. Such methods utilize novel compositions, including but not limited to extraembryonic cytokine secreting cells (herein referred to as ECS cells), including, but not limited to, amnion-derived multipotent progenitor cells (herein referred to as AMP cells), conditioned media derived therefrom (herein referred to as amnion-derived cellular cytokine solution or ACCS), cell lysates derived therefrom, and cell products derived therefrom, each alone or in combination.

Methods related to surgery

Compositions comprising physiologic concentrations of cytokines

Cellular factor-containing solution compositions

Growing community of inventors

Stormville, NY, United States of America

Linda O Palladino